Detalhe da pesquisa
1.
Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change.
Acta Neuropathol
; 146(1): 13-29, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269398
2.
Mid- and Late-Life Physical Activity and Neuropsychiatric Symptoms in Dementia-Free Older Adults: Mayo Clinic Study of Aging.
J Neuropsychiatry Clin Neurosci
; 35(2): 133-140, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464975
3.
Association between physical activity and longitudinal change in body mass index in middle-aged and older adults.
BMC Public Health
; 23(1): 202, 2023 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717834
4.
Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging.
Alzheimers Dement
; 19(10): 4498-4506, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142047
5.
Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.
Alzheimers Dement
; 18(6): 1128-1140, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34569696
6.
A longitudinal investigation of Aß, anxiety, depression, and mild cognitive impairment.
Alzheimers Dement
; 18(10): 1824-1831, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877794
7.
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
Am J Geriatr Psychiatry
; 29(2): 179-191, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646634
8.
Associations Between Plasma Ceramides and Cerebral Microbleeds or Lacunes.
Arterioscler Thromb Vasc Biol
; 40(11): 2785-2793, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878474
9.
Association of Cortical and Subcortical ß-Amyloid With Standardized Measures of Depressive and Anxiety Symptoms in Adults Without Dementia.
J Neuropsychiatry Clin Neurosci
; 33(1): 64-71, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086924
10.
Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging.
Int J Geriatr Psychiatry
; 36(9): 1362-1369, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724517
11.
Elevated Plasma Ceramides Are Associated With Higher White Matter Hyperintensity Volume-Brief Report.
Arterioscler Thromb Vasc Biol
; 39(11): 2431-2436, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31510790
12.
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
Alzheimers Dement
; 15(11): 1437-1447, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668594
13.
Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness.
Alzheimers Dement
; 13(2): 168-177, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27461490
14.
Functional Activity and Neuropsychiatric Symptoms in Normal Aging and Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
Alzheimer Dis Assoc Disord
; 33(1): 68-71, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30106755
15.
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly.
Sci Adv
; 10(14): eadk3674, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569027
16.
Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.
J Alzheimers Dis
; 92(4): 1131-1146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872783
17.
Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline.
Psychiatr Res Clin Pract
; 5(1): 4-15, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909142
18.
Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment.
J Alzheimers Dis Rep
; 7(1): 1237-1246, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38025797
19.
Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based study.
Alzheimers Dement (Amst)
; 15(3): e12461, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529120
20.
Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels.
Mol Neurodegener
; 17(1): 85, 2022 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575455